ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,370Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 783

$845K Total Retail Price of All Prescriptions

Rank: 79 out of 783

477 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 477 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 10,222 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 610 281 S3 1 2
FUROSEMIDE 497 373 2 7
SIMVASTATIN 402 324 3 3
LEVOTHYROXINE SODIUM 390 306 4 1
OMEPRAZOLE 361 259 5 6
LISINOPRIL 341 248 6 4
METFORMIN HCL 339 243 7 8
POTASSIUM CHLORIDE 331 272 8 16
WARFARIN SODIUM 321 255 9 10
GABAPENTIN 316 211 10 15
METOPROLOL TARTRATE 253 140 11 9
ZOLPIDEM TARTRATE 231 134 12 23
DONEPEZIL HCL 223 185 13 24
AMLODIPINE BESYLATE 222 172 14 5
PREDNISONE 210 171 15 36
DIGOXIN 195 163 16 61
PANTOPRAZOLE SODIUM 172 134 17 30
ALLOPURINOL 167 145 18 31
TRAMADOL HCL 158 121 19 20
FAMOTIDINE 146 87 20 55
CARISOPRODOL 146 33 R 20 168
NAMENDA 129 129 22 32
FLUOXETINE HCL 126 73 23 45
CARVEDILOL 123 110 24 21
LOSARTAN POTASSIUM 121 107 25 18
CLOPIDOGREL 117 88 26 29
OXYBUTYNIN CHLORIDE ER 115 88 27 117
NEXIUM 114 74 28 28
SERTRALINE HCL 106 81 29 22
AZITHROMYCIN 94 64 30 41
HYDROCHLOROTHIAZIDE 92 91 31 12
CITALOPRAM HBR 91 77 32 19
GLIPIZIDE 90 72 33 71
ISOSORBIDE MONONITRATE ER 87 77 34 40
MECLIZINE HCL 87 84 34 146
CIPROFLOXACIN HCL 84 52 36 62
PRAVASTATIN SODIUM 79 58 37 14
PROAIR HFA 79 32 37 56
KLOR-CON M20 77 56 39 48
TAMSULOSIN HCL 77 62 39 26
CEPHALEXIN 76 48 41 70
PLAVIX 75 61 42 51
LIDODERM 75 62 42 132
SPIRIVA 74 60 44 59
ATORVASTATIN CALCIUM 72 45 45 11
LOVASTATIN 72 65 45 58
AMITRIPTYLINE HCL 69 22 R 47 77
PRIMIDONE 67 41 48 230
ROPINIROLE HCL 67 42 48 74
FENTANYL 67 30 S2 48 65
FLUTICASONE PROPIONATE 66 45 51 46
ALENDRONATE SODIUM 64 55 52 25
METOPROLOL SUCCINATE 64 64 52 13
ATENOLOL 64 59 52 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 50 55 95
ADVAIR DISKUS 62 36 56 50
FINASTERIDE 61 38 57 127
DIOVAN 61 56 57 49
ALBUTEROL SULFATE 60 60 59 136
ESCITALOPRAM OXALATE 60 53 59 54
IPRATROPIUM-ALBUTEROL 58 57 61 110
ABILIFY 55 37 62 148
TRIAMTERENE-HCTZ 54 54 63 42
PROPRANOLOL HCL 54 43 63 129
CLOTRIMAZOLE-BETAMETHASONE 54 26 63 189
ENALAPRIL MALEATE 53 34 66 68
CYCLOBENZAPRINE HCL 53 27 R 66 63
KLOR-CON 10 53 30 66 102
QUETIAPINE FUMARATE 53 24 66 79
GLYBURIDE 52 40 R 70 111
CELEBREX 51 36 71 93
DICYCLOMINE HCL 50 22 72 200
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.